Early trial data demonstrated that Wegovy, which has been shown to help patients lose an average of 15% of their weight, also reduced incidence of heart attack, stroke or death from heart disease by 20%.
Well, the flip side of that argument comes with people who are in dire circumstances and want to try a drug for the potential benefits, but can’t because it hasn’t been approved yet. I think it’s perfectly fine to welcome the good news along with the bad. Science works with transparency.
Well, the flip side of that argument comes with people who are in dire circumstances and want to try a drug for the potential benefits, but can’t because it hasn’t been approved yet. I think it’s perfectly fine to welcome the good news along with the bad. Science works with transparency.